Skip to main content

uniQure N.V.

QURE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001590560

In the last 90 days, uniQure N.V. insiders filed 0 open-market purchases and 3 sales; 254 institutions reported holding it in 13F filings for Q2 2026, worth $3.02B in total; Maverick Capital is the only superinvestor holding it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by uniQure N.V. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
3 filings
3 insiders, $3.33M in total
Insiders trading
3
Net value
−$3.33M
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for uniQure N.V., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for uniQure N.V.
NameTitleLast reported holdingLast filingFilings, past year
Kapusta Matthew CCEO, Managing Director519,227Jul 7, 20266
Abi-Saab WalidChief Medical Officer148,235Jul 2, 20265
Kaye JackDirector25,996Jul 2, 20266
Balachandran MadhavanDirector43,254Jun 22, 20263
Potts JeannetteChief Legal Officer133,246Jun 17, 20263
Post Leonard EDirector35,494Jun 12, 20261
Meek David D.Director39,747Jun 12, 20261
Gut RobertDirector32,259Jun 12, 20263
Springhorn Jeremy P.Director43,251Jun 12, 20261
Jacques Rachelle SuzanneDirector33,903Jun 12, 20261
O'Keefe KylieChief Customer & Strat Officer108,864Jun 12, 20262
Klemt ChristianChief Financial Officer226,581Mar 6, 20263
Caloz PierreChief Operating Officer115,707Jun 20, 20240
Soteropoulos PaulaDirector20,203Jun 17, 20240
Dolmetsch RicardoPresident, R&D163,404Sep 20, 20230
Kuta Alexander Edward IIIExecutive VP, Operations90,381Mar 9, 20230

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Mar 1, 2023 (view filing)Feb 272 daysBalachandran MadhavanDirectorSSale−384$19.99−$7.68K−1.9%19.6K after
Mar 1, 2023 (view filing)Feb 27-282 daysKuta Alexander Edward IIIExecutive VP, OperationsSSale−6.73K$20.18−$135.7K−6.9%91.0K after2 lots
Mar 1, 2023 (view filing)Feb 272 daysPost Leonard EDirectorSSale−389$19.73−$7.67K−3.2%11.8K after
Mar 9, 2023 (view filing)Mar 72 daysKapusta Matthew CCEO, Managing DirectorSSale−2.52K$21.39−$53.9K−0.5%468.7K after
Mar 9, 2023 (view filing)Mar 72 daysDolmetsch RicardoPresident, R&DSSale−837$21.04−$17.6K−0.5%169.2K after
Mar 9, 2023 (view filing)Mar 72 daysKlemt ChristianChief Financial OfficerSSale−986$21.36−$21.1K−0.7%134.4K after
Mar 9, 2023 (view filing)Mar 72 daysKuta Alexander Edward IIIExecutive VP, OperationsSSale−585$21.36−$12.5K−0.6%90.4K after
Mar 9, 2023 (view filing)Mar 72 daysCaloz PierreChief Operating OfficerSSale−990$21.33−$21.1K−0.9%113.1K after
Jun 20, 2023 (view filing)Jun 164 daysSpringhorn Jeremy P.DirectorSSale−2.29K$18.88−$43.2K−8.1%26.0K after
Jun 20, 2023 (view filing)Jun 164 daysKlemt ChristianChief Financial OfficerSSale−1.59K$18.94−$30.1K−1.2%132.9K after
Jun 20, 2023 (view filing)Jun 164 daysCaloz PierreChief Operating OfficerSSale−2.92K$18.80−$54.9K−2.6%110.2K after
Jun 20, 2023 (view filing)Jun 164 daysBalachandran MadhavanDirectorSSale−2.28K$18.91−$43.2K−8.1%26.0K after
Jun 20, 2023 (view filing)Jun 164 daysGut RobertDirectorSSale−3.23K$18.88−$60.9K−6.3%47.7K after
Jun 20, 2023 (view filing)Jun 164 daysKaye JackDirectorSSale−2.28K$18.93−$43.2K−6.3%34.1K after
Jun 20, 2023 (view filing)Jun 164 daysMeek David D.DirectorSSale−2.29K$18.85−$43.2K−9.2%22.5K after
Jun 20, 2023 (view filing)Jun 164 daysPost Leonard EDirectorSSale−2.29K$18.83−$43.1K−11.2%18.2K after
Jun 20, 2023 (view filing)Jun 164 daysSoteropoulos PaulaDirectorSSale−2.27K$18.99−$43.2K−9.2%22.4K after
Jun 20, 2023 (view filing)Jun 164 daysJacques Rachelle SuzanneDirectorSSale−2.30K$18.76−$43.2K−12.2%16.6K after
Jul 12, 2023 (view filing)Jul 102 daysCaloz PierreChief Operating OfficerSSale−15.1K$11.36−$171.7K−13.7%95.1K after10b5-1
Sep 20, 2023 (view filing)Sep 182 daysDolmetsch RicardoPresident, R&DSSale−5.84K$7.46−$43.6K−3.5%163.4K after
Feb 28, 2024 (view filing)Feb 262 daysKapusta Matthew CCEO, Managing DirectorSSale−27.9K$6.35−$177.2K−6.0%440.8K after
Feb 28, 2024 (view filing)Feb 262 daysKlemt ChristianChief Financial OfficerSSale−15.9K$6.38−$101.5K−12.0%116.9K after
Feb 28, 2024 (view filing)Feb 262 daysCaloz PierreChief Operating OfficerSSale−9.46K$6.47−$61.2K−9.9%85.6K after
Jun 17, 2024 (view filing)Jun 134 daysJacques Rachelle SuzanneDirectorSSale−2.22K$5.14−$11.4K−13.4%14.4K after
Jun 17, 2024 (view filing)Jun 134 daysKaye JackDirectorSSale−2.22K$5.16−$11.4K−25.4%6.50K after
Jun 17, 2024 (view filing)Jun 134 daysGut RobertDirectorSSale−3.50K$5.12−$17.9K−7.4%44.2K after
Jun 17, 2024 (view filing)Jun 134 daysSoteropoulos PaulaDirectorSSale−2.22K$5.14−$11.4K−9.9%20.2K after
Jun 17, 2024 (view filing)Jun 134 daysBalachandran MadhavanDirectorSSale−2.23K$5.12−$11.4K−8.6%23.8K after
Jun 17, 2024 (view filing)Jun 134 daysMeek David D.DirectorSSale−2.23K$5.12−$11.4K−9.9%20.3K after
Jun 17, 2024 (view filing)Jun 134 daysSpringhorn Jeremy P.DirectorSSale−2.23K$5.12−$11.4K−8.6%23.8K after
Jun 17, 2024 (view filing)Jun 134 daysPotts JeannetteChief Legal OfficerSSale−4.78K$4.98−$23.8K−4.9%91.8K after
Jun 18, 2024 (view filing)Jun 135 daysLatePost Leonard EDirectorSSale−2.22K$5.14−$11.4K−12.2%16.0K after
Jun 20, 2024 (view filing)Jun 173 daysKlemt ChristianChief Financial OfficerSSale−1.61K$4.80−$7.73K−1.0%164.8K after
Jun 20, 2024 (view filing)Jun 173 daysCaloz PierreChief Operating OfficerSSale−2.94K$4.81−$14.1K−2.5%115.7K after
Jun 28, 2024 (view filing)Jun 262 daysAbi-Saab WalidChief Medical OfficerSSale−1.45K$4.36−$6.31K−1.2%115.3K after
Dec 10, 2024 (view filing)Dec 91 dayKlemt ChristianChief Financial OfficerSSale−1.80K$7.55−$13.6K−1.1%166.7K after
Dec 10, 2024 (view filing)Dec 91 dayKapusta Matthew CCEO, Managing DirectorSSale−3.42K$7.63−$26.1K−0.6%597.9K after
Dec 12, 2024 (view filing)Dec 102 daysKapusta Matthew CCEO, Managing DirectorSSale−100.0K$15.03−$1.50M−14.3%597.9K after10b5-1
Feb 27, 2025 (view filing)Feb 25-272 daysKlemt ChristianChief Financial OfficerSSale−17.3K$10.80−$186.5K−10.0%155.2K after2 lots
Feb 27, 2025 (view filing)Feb 25-272 daysKapusta Matthew CCEO, Managing DirectorSSale−33.4K$10.82−$362.0K−5.4%580.8K after2 lots
Mar 5, 2025 (view filing)Mar 41 dayPotts JeannetteChief Legal OfficerSSale−7.08K$10.29−$72.8K−5.6%119.7K after
Mar 5, 2025 (view filing)Mar 41 dayKlemt ChristianChief Financial OfficerSSale−10.4K$10.29−$107.4K−4.6%217.7K after
Mar 5, 2025 (view filing)Mar 41 dayAbi-Saab WalidChief Medical OfficerSSale−1.35K$10.29−$13.9K−0.9%151.9K after
Mar 5, 2025 (view filing)Mar 41 dayKapusta Matthew CCEO, Managing DirectorSSale−28.3K$10.29−$291.6K−4.2%651.5K after
Jun 20, 2025 (view filing)Jun 164 daysLatePotts JeannetteChief Legal OfficerSSale−4.67K$15.14−$70.7K−3.9%115.1K after
Jun 24, 2025 (view filing)Jun 204 daysMeek David D.DirectorSSale−2.11K$14.45−$30.5K−5.8%34.2K after
Jun 24, 2025 (view filing)Jun 204 daysBalachandran MadhavanDirectorSSale−2.11K$14.45−$30.5K−5.3%37.7K after
Jun 24, 2025 (view filing)Jun 204 daysGut RobertDirectorSSale−3.34K$14.45−$48.2K−5.5%56.9K after
Jun 24, 2025 (view filing)Jun 204 daysJacques Rachelle SuzanneDirectorSSale−2.11K$14.45−$30.5K−6.9%28.3K after
Jun 24, 2025 (view filing)Jun 204 daysKaye JackDirectorSSale−2.11K$14.45−$30.5K−9.4%20.4K after